Search results for:
Ondine Biomedical Presents Topline Results from Phase 3 LANTERN Trial
This Announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation No. 596/2014 as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 as amended. Upon the publication of this Announcement, this inside information is now considered to be [...]
Ondine Biomedical Announces Positive Topline Results from Phase 3 Pivotal LANTERN Study
This Announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation No. 596/2014 as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018 as amended. Upon the publication of this Announcement, this inside information is now considered to [...]
For Media Information
5654 & Company
